3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators.

3D printing COVID-19 KN95 masks N95 respirators filtering face piece (FFP) respirator mask frames occupational health pandemic response personal protective equipment (PPE) prototyping

Journal

BMC biomedical engineering
ISSN: 2524-4426
Titre abrégé: BMC Biomed Eng
Pays: England
ID NLM: 101756092

Informations de publication

Date de publication:
07 Jun 2021
Historique:
received: 23 07 2020
accepted: 09 05 2021
entrez: 8 6 2021
pubmed: 9 6 2021
medline: 9 6 2021
Statut: epublish

Résumé

In response to supply shortages caused by the COVID-19 pandemic, N95 filtering facepiece respirators (FFRs or "masks"), which are typically single-use devices in healthcare settings, are routinely being used for prolonged periods and in some cases decontaminated under "reuse" and "extended use" policies. However, the reusability of N95 masks is limited by degradation of fit. Possible substitutes, such as KN95 masks meeting Chinese standards, frequently fail fit testing even when new. The purpose of this study was to develop an inexpensive frame for damaged and poorly fitting masks using readily available materials and 3D printing. An iterative design process yielded a mask frame consisting of two 3D printed side pieces, malleable wire links that users press against their face, and cut lengths of elastic material that go around the head to hold the frame and mask in place. Volunteers (n = 45; average BMI = 25.4), underwent qualitative fit testing with and without mask frames wearing one or more of four different brands of FFRs conforming to US N95 or Chinese KN95 standards. Masks passed qualitative fit testing in the absence of a frame at rates varying from 48 to 94 % (depending on mask model). For individuals who underwent testing using respirators with broken or defective straps, 80-100 % (average 85 %) passed fit testing with mask frames. Among individuals who failed fit testing with a KN95, ~ 50 % passed testing by using a frame. Our study suggests that mask frames can prolong the lifespan of N95 and KN95 masks by serving as a substitute for broken or defective bands without adversely affecting fit. Use of frames made it possible for ~ 73 % of the test population to achieve a good fit based on qualitative and quantitative testing criteria, approaching the 85-90 % success rate observed for intact N95 masks. Frames therefore represent a simple and inexpensive way of expanding access to PPE and extending their useful life. For clinicians and institutions interested in mask frames, designs and specifications are provided without restriction for use or modification. To ensure adequate performance in clinical settings, fit testing with user-specific masks and PanFab frames is required.

Sections du résumé

BACKGROUND BACKGROUND
In response to supply shortages caused by the COVID-19 pandemic, N95 filtering facepiece respirators (FFRs or "masks"), which are typically single-use devices in healthcare settings, are routinely being used for prolonged periods and in some cases decontaminated under "reuse" and "extended use" policies. However, the reusability of N95 masks is limited by degradation of fit. Possible substitutes, such as KN95 masks meeting Chinese standards, frequently fail fit testing even when new. The purpose of this study was to develop an inexpensive frame for damaged and poorly fitting masks using readily available materials and 3D printing.
RESULTS RESULTS
An iterative design process yielded a mask frame consisting of two 3D printed side pieces, malleable wire links that users press against their face, and cut lengths of elastic material that go around the head to hold the frame and mask in place. Volunteers (n = 45; average BMI = 25.4), underwent qualitative fit testing with and without mask frames wearing one or more of four different brands of FFRs conforming to US N95 or Chinese KN95 standards. Masks passed qualitative fit testing in the absence of a frame at rates varying from 48 to 94 % (depending on mask model). For individuals who underwent testing using respirators with broken or defective straps, 80-100 % (average 85 %) passed fit testing with mask frames. Among individuals who failed fit testing with a KN95, ~ 50 % passed testing by using a frame.
CONCLUSIONS CONCLUSIONS
Our study suggests that mask frames can prolong the lifespan of N95 and KN95 masks by serving as a substitute for broken or defective bands without adversely affecting fit. Use of frames made it possible for ~ 73 % of the test population to achieve a good fit based on qualitative and quantitative testing criteria, approaching the 85-90 % success rate observed for intact N95 masks. Frames therefore represent a simple and inexpensive way of expanding access to PPE and extending their useful life. For clinicians and institutions interested in mask frames, designs and specifications are provided without restriction for use or modification. To ensure adequate performance in clinical settings, fit testing with user-specific masks and PanFab frames is required.

Identifiants

pubmed: 34099062
doi: 10.1186/s42490-021-00055-7
pii: 10.1186/s42490-021-00055-7
pmc: PMC8182357
doi:

Types de publication

Journal Article

Langues

eng

Pagination

10

Subventions

Organisme : NCI NIH HHS
ID : U54 CA225088
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32-GM007753
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States
Organisme : Harvard MIT Center for Regulatory Sciences
ID : Harvard MIT Center for Regulatory Sciences
Organisme : NCI NIH HHS
ID : U54-CA225088
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

JAMA. 2020 Jul 7;324(1):94-96
pubmed: 32496504
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
PLoS One. 2020 Jul 1;15(7):e0234851
pubmed: 32609741
PLoS One. 2017 Nov 27;12(11):e0188638
pubmed: 29176833
MMWR Morb Mortal Wkly Rep. 2021 Feb 19;70(7):254-257
pubmed: 33600386
Sci Rep. 2021 Jan 21;11(1):2051
pubmed: 33479334
Front Bioeng Biotechnol. 2021 Sep 06;9:690905
pubmed: 34552915
Am J Infect Control. 2008 May;36(4):298-300
pubmed: 18455051
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1011-6
pubmed: 20731598
Ann Occup Hyg. 2009 Nov;53(8):815-27
pubmed: 19805391
Front Digit Health. 2021 Mar;3:
pubmed: 33899045
Am J Infect Control. 2012 May;40(4):375-80
pubmed: 21864945
Am J Infect Control. 2009 Dec;37(10):e5-e16
pubmed: 20004810
Am J Infect Control. 2013 Nov;41(11):1024-31
pubmed: 23932825
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
BMC Infect Dis. 2021 Jul 29;21(1):712
pubmed: 34325673
3D Print Med. 2020 Apr 27;6(1):11
pubmed: 32337613
Int Endod J. 2020 May;53(5):723-725
pubmed: 32277770
BMC Infect Dis. 2019 Jun 3;19(1):491
pubmed: 31159777
Infect Control Hosp Epidemiol. 2010 Sep;31(9):918-25
pubmed: 20658919
Int J Oral Sci. 2020 Mar 3;12(1):9
pubmed: 32127517
BMJ Open. 2020 Jul 7;10(7):e039120
pubmed: 32641368
J Virol Methods. 2015 Oct;223:13-8
pubmed: 26190637
Ann Work Expo Health. 2019 Oct 11;63(8):930-936
pubmed: 31504129
J Occup Environ Hyg. 2013;10(8):419-24
pubmed: 23767820

Auteurs

Malia McAvoy (M)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Department of Neurosurgery, University of Washington, Seattle, WA, USA.

Ai-Tram N Bui (AN)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Christopher Hansen (C)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard Graduate School of Design, Cambridge, MA, USA.

Deborah Plana (D)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.
Department of Systems Biology, Harvard Ludwig Cancer Research Center, Harvard Medical School, Boston, MA, USA.

Jordan T Said (JT)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Zizi Yu (Z)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Helen Yang (H)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.

Jacob Freake (J)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Fikst Product Development, Woburn, MA, USA.

Christopher Van (C)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Borobot, Middleborough, MA, USA.

David Krikorian (D)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Dana-Farber Cancer Institute, MA, Boston, USA.

Avilash Cramer (A)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.

Leanne Smith (L)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Borobot, Middleborough, MA, USA.

Liwei Jiang (L)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.

Karen J Lee (KJ)

Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.

Sara J Li (SJ)

Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.

Brandon Beller (B)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Engineering Science at Norwalk Community College, Norwalk, CT, USA.

Kimberley Huggins (K)

Harvard Graduate School of Design, Cambridge, MA, USA.

Michael P Short (MP)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Department of Nuclear Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

Sherry H Yu (SH)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.

Arash Mostaghimi (A)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.

Peter K Sorger (PK)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA. peter_sorger@hms.harvard.edu.
Department of Systems Biology, Harvard Ludwig Cancer Research Center, Harvard Medical School, Boston, MA, USA. peter_sorger@hms.harvard.edu.
Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA, USA. peter_sorger@hms.harvard.edu.

Nicole R LeBoeuf (NR)

Greater Boston Pandemic Fabrication Team (PanFab) c/o Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA, USA. nleboeuf@bwh.harvard.edu.
Harvard Medical School, Boston, MA, USA. nleboeuf@bwh.harvard.edu.
Dana-Farber Cancer Institute, MA, Boston, USA. nleboeuf@bwh.harvard.edu.
Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. nleboeuf@bwh.harvard.edu.

Classifications MeSH